Brain & Performance Centre signs MOU with UAE Athletic Commission
The Brain & Performance Centre, a subsidiary of logistics conglomerate DP World, has signed a Memorandum of Understanding with the UAE Athletic Commission to provide pre-fight brain health assessments for professional boxers competing in sanctioned events across the UAE.
Under the agreement, the Centre joins the Commission's roster of approved medical service providers. All professional boxers in sanctioned UAE events are already required to complete a mandatory MRI examination as part of medical clearance. The new partnership adds an optional layer: a broader neurological and performance assessment covering cognitive function, reaction time and balance, using what the Centre describes as scientifically validated protocols and advanced technologies. The Centre did not name specific devices or assessment tools in its announcement.
Chief executive Craig Cook described the arrangement as "an important milestone" in the Centre's mission to advance brain health through science, adding that the initiative gives athletes "the opportunity to gain a more comprehensive understanding of their brain health and performance." UAE Athletic Commission boxing commissioner Pat Fiacco said the partnership "reinforces our commitment to the highest international standards in athlete health and safety" and sets a benchmark as boxing grows across the region.
Rollout is expected later this year, with referral logistics and scheduling details still to be confirmed by the two organisations.
Market context
Athlete brain health has become a growing priority across combat sports globally, driven by accumulating evidence on the long-term neurological consequences of repetitive head impacts. Regulatory bodies in the United States, the United Kingdom and Australia have each tightened pre-fight medical clearance requirements over the past decade, and the use of baseline cognitive testing is now standard practice in several major boxing jurisdictions.
The optional nature of the Centre's broader assessment is notable. Combat sports governing bodies in other markets have faced resistance when attempting to mandate neurological screening beyond standard MRI, partly because of cost and scheduling constraints for athletes competing across multiple jurisdictions. Making the assessment voluntary lowers the barrier to adoption and may generate longitudinal data on participating fighters, though the absence of a mandatory requirement limits the programme's reach from a public-health standpoint.
Competitive positioning
The Brain & Performance Centre positions itself as a premium, technology-led clinic rather than a conventional sports medicine provider. Its parent, DP World, is primarily a port and logistics operator, making this a diversified healthcare venture rather than a core life-sciences play. The Dubai facility uses hyperbaric oxygen therapy as a centrepiece of its treatment protocols, a modality that carries a mixed evidence base in elite sport contexts and has attracted regulatory scrutiny in some markets. The partnership with the UAE Athletic Commission grants the Centre a degree of official endorsement that could support commercial referrals and international reputation building in the Gulf region's expanding sports sector.
Whether the model proves exportable beyond the UAE will depend on whether the optional assessment programme generates outcome data compelling enough to influence other athletic commissions, and on how the Centre navigates questions of clinical evidence for some of its proprietary protocols.